Skip to main content

Table 3 Differences in the physical performance, muscle strength and body-composition among locomotive syndrome stages

From: Prevalence and physical characteristics of locomotive syndrome stages as classified by the new criteria 2020 in older Japanese people: results from the Nagahama study

 

Non-LS

LS stage 1

LS stage 2

LS stage 3

F-value

p-value

Post-hoc test

n = 1319

n = 507

n = 115

n = 136

Univariate

Multivariate

Usual gait speed, m/s

1.33 (0.17)

1.26 (0.17)

1.24 (0.18)

1.13 (0.21)

71.06

< 0.001

1, 2, 3, 5, 6

1, 2, 3, 5, 6

Five-times chair-stand, s

8.25 (2.23)

9.07 (2.60)

9.66 (2.84)

10.6 (3.89)

49.47

< 0.001

1, 2, 3, 5, 6

1, 2, 3, 5, 6

Single-leg standing, s

47.37 (18.26)

41.47 (20.98)

37.79 (22.06)

30.43 (22.19)

41.87

< 0.001

1, 2, 3, 5, 6

1, 2, 3, 5, 6

SPPB, /total of 12

11.82 (0.52)

11.66 (0.76)

11.49 (0.97)

11.17 (1.30)

44.18

< 0.001

1, 2, 3, 5, 6

1, 2, 3, 5, 6

Grip power, kg

29.23 (8.82)

27.07 (8.38)

27.50 (9.00)

25.29 (7.83)

14.31

< 0.001

1, 3

1, 2, 3

Knee extension strength, Nm

121.28 (50.95)

111.52 (47.52)

108.52 (47.90)

97.63 (47.46)

13.25

< 0.001

1, 2, 3, 5

1, 2, 3, 4, 5

Hip flexion strength, Nm

43.96 (16.15)

39.49 (14.23)

37.73 (13.23)

35.73 (14.02)

22.01

< 0.001

1, 2, 3

1, 2, 3

Hip abduction strength, Nm

25.36 (7.78)

22.99 (7.55)

22.61 (8.03)

20.20 (7.79)

27.68

< 0.001

1, 2, 3, 5

1, 2, 3, 4, 5

SMI, kg/m2

6.65 (0.93)

6.57 (0.90)

6.77 (1.04)

6.59 (1.00)

1.94

0.121

–

–

ECW/ICW ratio, a.u

4.66 (0.64)

4.81 (0.62)

4.84 (0.66)

5.13 (0.78)

25.84

< 0.001

1, 2, 3, 5, 6

1, 2, 3, 4, 5, 6

  1. The general linear model was used for univariate and multivariate analyses, and post-hoc test was performed to assess the differences among the groups. The values of F-value and p-value represent the results of univariate analysis. The number indicates a significant difference by the post hoc test: 1, Non-LS versus LS stage 1; 2, Non-LS versus LS stage 2; 3, Non-LS versus LS stage 3; 4, LS stage1 versus stage 2; 5, LS stage 1 versus stage 3; 6, LS stage 2 versus stage 3
  2. LS locomotive syndrome, SPPB short physical performance battery, SMI skeletal muscle mass index, ECW/ICW extracellular-to-intracellular water